SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
PRNewsWire
·
2026-06-15
·
via The Tech Buzz - Press Releases
Key Facts: FDA has accepted for review the New Drug Application (NDA) for an investigational oral suspension …
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。